Ondansetron ODT 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F8ND2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,776
Award facts
- Contract value 100% obligated
- $5,776.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 26, 2026, for the supply of Ondansetron Orally Disintegrating Tablet 8 milligram, 30-count packages, with a ceiling value of $5,776.05. The contract utilizes a firm fixed-price structure with an ultimate completion date of January 27, 2026, and represents a non-set-aside competitive award. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with performance taking place at its corporate office location. The company is a subsidiary of parent corporation Cencora, Inc., a major pharmaceutical distributor providing comprehensive medical supply solutions to federal agencies.
This delivery order falls under AmerSourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The delivery order for Ondansetron, an anti-nausea medication commonly used in military medical settings, exemplifies the company's role in providing essential pharmaceutical support to the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F8ND2?
SPE2DR26F8ND2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F8ND2 worth?
The government has obligated $5,776 on SPE2DR26F8ND2.
Is contract SPE2DR26F8ND2 an order under another contract?
Yes. SPE2DR26F8ND2 is a delivery order under SPE2DR25D3517, an indefinite delivery contract.
Was contract SPE2DR26F8ND2 competed?
The extent of competition for SPE2DR26F8ND2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award